The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis

Psycho-Oncology

Volumn 18, Issue 6, 2009, Pages 589-597

  Nieuwenhuijsen, Karen ^a   de Boer, Angela ^a   Spelten, Evelien ^b   Sprangers, Mirjam A G ^a   Verbeek, Jos H A M ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Midwifery Academy Amsterdam   (Netherlands)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Cancer; Cognition disorders; Neuropsychological tests; Oncology; Return to work

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVOR; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; VERBAL MEMORY; WORK RESUMPTION;

ADULT; BRAIN DAMAGE, CHRONIC; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHOMETRICS; REHABILITATION, VOCATIONAL; REPRODUCIBILITY OF RESULTS; SICK LEAVE;

EID: 67949103657     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1439     Document Type: Article

References (36)

1. Rowland JH, Yancik R. Cancer survivorship: the interface of aging, comorbidity, and quality care. J Natl Cancer Inst 2006; 98:504-505.
2. Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol. 2002;41: 229-237.
3. Ferrell BR, Grant MM, Funk B, Otis-Green S, Garcia N. Quality of life in breast cancer survivors as identified by focus groups. Psycho-Oncology 1997;6:13-23.
4. Main DS, Nowels CT, Cavender TA, Etschmaier M, Steiner JF. A qualitative study of work and work return in cancer survivors. Psycho-Oncology 2005;14: 992-1004.
5. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003; 58:82-91.
6. Spelten ER, Sprangers MA, Verbeek JH. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-Oncology 2002;11:124-131.
7. Spelten ER, Verbeek JH, Uitterhoeve AL et al. Cancer, fatigue and the return of patients to work - a prospective cohort study. Eur J Cancer 2003;39:1562-1567.
8. Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psycho-Oncology 2002;11:188-198.
9. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9: 967-982.
10. Falleti MG, Sanfilippo A, Maru. P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 2005;59:60-70.
11. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006; 20:76-89.
12. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008; 19:623-629.
13. Bloom JR, Hoppe RT, Fobair P, Cox RS, Varghese A, Spiegel D. Effects of treatment on the work experiences of long-term survivors of Hodgkin's disease. J Psychosoc Oncol 1988;6: 65-80.
14. Reid-Arndt SA. The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. Neuro Rehabilitation 2006;21:51-64.
15. van Dam FS, Schagen SB, Muller MJ et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-218.
16. Servaes P, Verhagen CA, Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 2002;95:2017-2026.
17. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 1996;74:1674-1679.
18. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
19. Schmand B, Lindeboom J, van Harskamp F. National Adult Reading Test Dutch version [Nederlandse Leestest voor volwassenen]. Swets & Zeitlinger: Amsterdam, 1992.
20. Berger H, Kunst M, Deelman BG. [Dutch Reading tests for adults]. Tijdschr Gerontol Geriatr 1996;27: 250-254.
21. Wechsler D. W0echsler Memory Scale- Revised: Manual. Psychological Corporation: San Antonio, TX, 1987.
22. Wechsler D. Wechsler Adult Intelligence Scale - Revised. Psychological Corporation: San Antonio, TX, 1981.
23. Wilson B, Cockburn J, Baddeley AD. The Rivermead Behavioral Memory Test. Thames Valley Test Company: Bury St Edmunds, UK, 1985.
24. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18: 643-662.
25. Reitan RM, Davison LA. Clinical Neuropsychology: Current Status and Application. Hemisphere Publishing Corporation: New York, 1974.
26. Gronwall DMA, Sampson H. The Psychological Effects of Concussion. Auckland University Press: Auckland, New Zealand, 1974.
27. Snijders J, Luteijn F, van der Ploeg F, Verhage F. Handleiding Groninger intelligentie test. Swets & Zeitlinger: Lisse, 1983
28. Smets E, Garssen G, Bonke B, de Haes JCJM. The Multidimensional Fatigue Inventory, psychometric qualities of an instrument to assess fatigue. J Psychometric Res 1995;39:315-325.
29. Radloff LS. The CES-D Scale, a self-report depression scale for research in the general population. Appl Psych Meas 1977;3:385-401.
30. Tuomi K, Ilmarinen J, Jahkola A, Katajarinne L, Tulkki A. Work Ability Index. Finnish Institute of Occupational Health: Helsinki, 1998.
31. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 2004; 101:466-475.
32. Hermelink K, Untch M, Lux MP et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007; 109(9):1905-1913.
33. Jenkins V, Shilling V, Deutsch G et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94(6):828-834.
34. Servaes P, Verhagen CA, Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 2002;95:2017-2026.
35. Shilling V, Jenkins V, Trapala IS. The (mis)classification of chemo-fog- methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 2006; 95:125-129.
36. Ingraham L, Aiken CB. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996;10: 120-124.